These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2416588)

  • 1. Cytotoxicity of human peripheral blood T-lymphocyte clones activated by hepatitis B virus surface antigen.
    Hakim AA
    Experientia; 1985 Dec; 41(12):1579-84. PubMed ID: 2416588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.
    Celis E; Kung PC; Chang TW
    J Immunol; 1984 Mar; 132(3):1511-6. PubMed ID: 6198394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B surface antigen specific cytotoxic T lymphocyte activity in hepatitis B virus infection.
    Onishi S; Saibara T; Ito K
    Gastroenterol Jpn; 1985 Aug; 20(4):330-7. PubMed ID: 3876961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
    J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of hepatitis B surface antigen (HBsAg)-specific cytotoxic T cells in asymptomatic HBsAg carriers.
    Shu PY; Lin MY; Chang C; Hwang LH; Huang JH; Chang TH; Hu C
    J Infect Dis; 1994 Mar; 169(3):633-7. PubMed ID: 7512610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen.
    Celis E; Chang TW
    Science; 1984 Apr; 224(4646):297-9. PubMed ID: 6231724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.
    Alberti A; Realdi G; Bortolotti F; Rigoli AM
    Gut; 1977 Dec; 18(12):1004-9. PubMed ID: 304824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells].
    Lei CL; Huang CH; Yang Z; Tang XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):108-10. PubMed ID: 17653306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.
    Le Borgne S; Mancini M; Le Grand R; Schleef M; Dormont D; Tiollais P; Rivière Y; Michel ML
    Virology; 1998 Jan; 240(2):304-15. PubMed ID: 9454704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid.
    Actis GC; Ponzetto A; D'Urso N; Saracco G; Crepaldi T; Bellone G; Catucci LM; Zarcone D; Verme G
    Liver; 1991 Apr; 11(2):106-13. PubMed ID: 1646927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.
    Mieli-Vergani G; Vergani D; Portmann B; White Y; Murray-Lyon I; Marigold JH; Woolf I; Eddleston AL; Williams R
    Gut; 1982 Dec; 23(12):1029-36. PubMed ID: 6983473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.
    Chisari FV; Bieber MS; Josepho CA; Xavier C; Anderson DS
    J Immunol; 1981 Jan; 126(1):45-9. PubMed ID: 6450241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B.
    Löhr HF; Gerken G; Schlicht HJ; Meryer zum Büschenfelde KH; Fleischer B
    J Infect Dis; 1993 Nov; 168(5):1133-9. PubMed ID: 8228346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
    Steward MW; Sisley BM; Stanley C; Brown SE; Howard CR
    Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
    Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
    J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.